Dermatologist Dr. David Fiorentino is excited about the possibilities of cell therapies to treat autoimmune conditions like dermatomyositis (DM). In collaboration with rheumatologists and bone marrow transplant specialists at Stanford University, he is conducting a small, phase 1b clinical trial testing KYV-101, a CAR T cell therapy that targets a protein called CD19 on the…
Continue ReadingFMLA leave for clinical trial participation
The Family and Medical Leave Act (FMLA) has long been a cornerstone of employee rights in the United States, providing eligible employees with up to 12 weeks of unpaid, job-protected leave for various family and medical reasons. In an opinion letter dated November 8, the US Department of Labor (DOL) clarified that FMLA leave can…
Continue ReadingBetter Medicare Part D benefits for 2025
Two important changes have been made to Medicare Part D in 2025 that may help make the cost of your prescription drugs more affordable and more manageable.
Continue ReadingNIH hosts visit for people with myositis
By Lindsay Key People living with myositis learned about research to advance understanding and treatment of the disease during presentations and a tour of the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland on Sept. 6. Myositis refers to a set of autoimmune diseases involving chronic inflammation of the muscles. An estimated 75,000…
Continue ReadingTMA’s Women of Color raise the bar for advocacy and support
Kaniah Gunter and Holly Jones
Continue Reading